AngioDynamics (NSDQ:ANGO) said today its CFO and exec veep Mark Frost resigned from his position to join Analogic (NSDQ:ALOG) as senior veep, treasurer & CFO.
AngioDynamic’s veep and global controller Michael Trimach will serve as Interim CFO as the company searches for a permanent replacement. The Albany, N.Y.-based company said Frost will stay on to facilitate a smooth transition of duties to the new CFO.
“On behalf of the entire AngioDynamics team, I would like to extend my thanks and appreciation to Mark for his leadership over the past 3 years and wish him the best in his future endeavors,” CEO Joseph DeVivo said in a press release.
Analogic said Frost will take up his role as CFO of the Peabody, Mass.-based company effective November 30.
“We are very happy to have Mark join Analogic. He is a seasoned CFO with substantial healthcare industry experience who will provide sound financial and strategic leadership as we continue to grow and improve our profitability in our medical and security businesses. Mark will also play an important role in expanding our direct medical business. I see Mark as an excellent fit for Analogic and welcome him to our team,” Analogic CEO Jim Green said in a prepared statement.
“Analogic has an exciting future. Analogic is a growing, dynamic technology company serving key medical and security markets worldwide. I look forward to the opportunity to help the company expand on its already strong foundation,” Frost said in prepared remarks.
Frost took over as AngioDynamic’s CFO in late 2012, when previous exec veep & CFO Joseph Gersuk retired. Prior to AngioDynamics, Frost was VP of finance at Smith & Nephew (NYSE:SNN) Endoscopy and CFO of Groupe Sovac Auto financial services at GE (NYSE:GE) in Paris, France.
TransEnterix sales veep is MedTech, Intuitive vet Boudrez
TransEnterix (NYSE:TRXC) said last week it picked up Steven Boudrez as its European veep of sales. Boudrez previously spent 12 years with DaVinci developer Intuitive Surgical (NSDQ:ISRG) and comes to TransEnterix from a European sales veep position with MedTech S.A.
Read more
Cardica picks up ex-ReVascular CEO Palermo as COO
Cardica (NSDQ:CRDC) said last week it picked up Thomas Palermo as its new COO. Palermo comes from start-up chronic wound care company UlceRX where he served as CEO, and was previously CEO of ReVascular Therapeutics, which was acquired by Boston Scientific (NYSE:BSX) in 2011.
Read more
Asana tags Ex-Neurologix CDO Sapan as new prez
Asana Medical said today it picked up Dr. Christine Sapan as its new president, taking over duties from founder and former CEO Marc Ramer. Sapan previously worked for 6 years as CDO of Neurologix.
Read more
RIP medtech pioneer Jako
Dr. Geza Jako, a renowned surgeon who helped develop the 1st microsurgical instruments, had a hand in developing the 1st cochlear implants and became recognized worldwide as “the father of laser surgery,” died Nov. 1 at age 85. Jako, who fought the occupying Soviet Union during the Hungarian Revolution of 1956, emigrated to the U.S. soon after and helped invent the nascent fields of soft tissue microsurgery, laser surgery, and modern techniques of minimally invasive surgery. Over the course of hiis career, Dr. Jako generated more than 150 publications, including textbook chapters, and 7 US patents relating to minimally invasive, micro- and laser surgery. There are over 120 surgical instruments bearing his name made by several leading medical device companies.
Read more
- New BAX CEO Almeida steps down from board
- Battelle appoints Jefferies as medical advisor
- Evolent adds to board
- Rennova Health announces post-merger board
- Ventripoint adds Willis to board
